Literature DB >> 24277221

Metabolism and distribution of primaquine in monkeys.

J K Baker1, J A Bedford, A M Clark, J D McChesney.   

Abstract

Rhesus monkeys were administered primaquine diphosphate (6.0 to 10.5 mg/kg, I.V.), and plasma samples were analyzed by high performance liquid chromatography for the presence of the unchanged drug and the major metabolite , 8-(3-carboxy-l-methylpropylamino)-6-methoxyquinoline (II). Primaquine had an unusually high affinity for tissue compartments which produced a rapid initial drop in plasma concentration. Within 15 minutes, the plasma concentration of II far exceeded that of primaquine. 35 to 83 % of the primaquine dose was converted to II; moreover, metabolite II possessed much lower affinity for the tissue compartments than primaquine itself.

Entities:  

Year:  1984        PMID: 24277221     DOI: 10.1023/A:1016363600790

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

Review 1.  Drug-induced hemolytic anemia.

Authors:  E Beutler
Journal:  Pharmacol Rev       Date:  1969-03       Impact factor: 25.468

2.  Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs.

Authors:  T C Orton; M W Anderson; R D Pickett; T E Eling; J R Fouts
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

3.  Primaquine: metabolism by microorganisms and 13C nuclear magnetic resonance assignments.

Authors:  A M Clark; C D Huford; J D McChesney
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite.

Authors:  J K Baker; J D McChesney; C D Hufford; A M Clark
Journal:  J Chromatogr       Date:  1982-06-11
  4 in total
  8 in total

1.  Selective toxicity of the antimalarial primaquine-evidence for both uncoupling and inhibitory effects of a metabolite on the energetics of mitochondria and its ATP synthase complex.

Authors:  J K Baker; J M Hullihen; P L Pedersen
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

2.  Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.

Authors:  M J Portela; R Moreira; E Valente; L Constantino; J Iley; J Pinto; R Rosa; P Cravo; V E do Rosário
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

3.  The pharmacokinetics of primaquine in calves after subcutaneous and intravenous administration.

Authors:  H Yoshimura; Y S Endoh; Y Ishihara; S Nakamura; Y Inoue
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

4.  Effect of aliphatic side-chain substituents on the antimalarial activity and on the metabolism of primaquine studied using mitochondria and microsome preparations.

Authors:  J K Baker; R H Yarber; N P Nanayakkara; J D McChesney; F Homo; I Landau
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

5.  Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.

Authors:  N P Dhammika Nanayakkara; Babu L Tekwani; H M T Bandara Herath; Rajnish Sahu; Montip Gettayacamin; Anchalee Tungtaeng; Yvonne van Gessel; Paul Baresel; Kristina S Wickham; Marilyn S Bartlett; Frank R Fronczek; Victor Melendez; Colin Ohrt; Gregory A Reichard; James D McChesney; Rosemary Rochford; Larry A Walker
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

6.  Fungal metabolism of 4-methylprimaquine.

Authors:  A M Clark; J D McChesney; C D Hufford
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

7.  Excretion of metabolites in bile following the administration of primaquine to rats.

Authors:  J K Baker; J D McChesney; L A Walker
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

8.  Characterization of the urinary metabolites of primaquine in rats.

Authors:  J K Baker; J D McChesney; L F Jorge
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.